• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 6
      Medicare Advantage’s supplemental benefits will cost taxpayers $86 billion this year, with little transparency - 11 hour(s) ago

      Taxpayers will send an estimated $86 billion to Medicare Advantage insurers this year to pay for supplemental benefits for their members, or 17% of total

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	statnews
        statnews

        Taxpayers will send an estimated $86 billion to Medicare Advantage insurers this year to pay for supplemental benefits for their members, or 17% of total payments to those plans. But… https://t.co/TBhRDbL9v0

    • Mashup Score: 6
      Physical Activity Profiles: Couch Potato, Weekend Warrior, Ant and Koala - Dr Tikkanen - 14 hour(s) ago

      Explore the concept of physical activity profiles, which categorizes individuals based on their levels of physical activity and sedentary behavior. This appr…

      Source: www.youtube.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	PA_Researcher
        PA_Researcher

        RT @OlliTikkanen: https://t.co/qK3QxvaG9U

    • Mashup Score: 11
      Advanced Imaging for Focal Therapy in Intermediate Risk Prostate Cancer - Matthew Cooperberg - 2 day(s) ago

      Zachary Klaassen speaks with Matthew Cooperberg about the integration of OnQ™ Prostate assisted Focal One® Robotic HIFU for prostate cancer treatment. Dr. Cooperberg discusses how appropriate candidate selection for focal therapy has evolved, emphasizing that focal therapy should be viewed as an adjunct to active surveillance rather than an alternative to radical treatment. He explains that the…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        Advanced imaging for #FocalTherapy in intermediate-risk #ProstateCancer. @dr_coops @UCSFCancer and @zklaassen_md @GACancerCenter discuss the integration of OnQ™ Prostate assisted Focal One® Robotic HIFU for prostate cancer treatment. #WatchNow > https://t.co/gTpjtow1VH https://t.co/B8qvFdpL0H

    • Mashup Score: 10
      The Art of the Pivot | Hopkins Bloomberg Public Health Magazine - 2 day(s) ago

      Pandemics. Wars. Existential financial threats. The Bloomberg School has long used its hard-won experience to anticipate and shape the future.

      Source: magazine.publichealth.jhu.edu
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	JohnsHopkinsSPH
        JohnsHopkinsSPH

        Pandemics. Wars. Existential financial threats. The Bloomberg School has long used its hard-won experience to anticipate and shape the future. https://t.co/vyBOGcwNQe

    • Mashup Score: 9
      Interaction molecular QTL mapping discovers cellular and environmental modifiers of genetic regulatory effects - 2 day(s) ago

      To identify regulatory variants with plasticity in effect size, we performed interaction molecular quantitative trait loci (iQTL) mapping with cell-type abundance, age, sex, and smoking as the environmental factors. Our results highlight the usefulness of iQTLs for gaining insights into the context specificity of regulatory effects.

      Source: www.cell.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	CellPressNews
        CellPressNews

        Interaction molecular QTL mapping discovers cellular and environmental modifiers of genetic regulatory effects by @silvakasela et al. https://t.co/e6YvZnvTRI Collection highlight from @AJHGNews (@GeneticsSociety) https://t.co/VUlzefXL2i

    • Mashup Score: 0
      India's Sun Pharma names Kirti Ganorkar as managing director - 3 day(s) ago

      Sun Pharmaceutical , India’s largest drugmaker by revenue, on Friday named Kirti Ganorkar as managing director, effective September 1.

      Source: www.reuters.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	Reuters_Health
        Reuters_Health

        Sun Pharmaceutical , India's largest drugmaker by revenue, on Friday named Kirti Ganorkar as managing director, effective September 1. https://t.co/1zXLpOlCIw https://t.co/1zXLpOlCIw

    • Mashup Score: 3
      Up and down the ladder: The latest comings and goings - 3 day(s) ago

      From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	statnews
        statnews

        From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. https://t.co/upSPouIhQD

    • Mashup Score: 27
      Real-World Evidence Informs Clinical Decision-Making in Metastatic Castration-Resistant Prostate Cancer - Alan Bryce - 3 day(s) ago

      Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alan Bryce, MD, Chief Clinical Officer, City of Hope Cancer Center Pheonix, Phoenix, Arizona Elena Castro, MD, PhD, Hospital Universitario 12 de Octubre, Madrid, Spain Related Content: An Overview in…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        Real-world evidence informs clinical decision-making in metastatic castration-resistant #ProstateCancer. @AlanBryce9 @cityofhope joins @Ecastromarcos in this discussion as part of an Independent Medical Education Initiative supported by @BayerPharma > https://t.co/W3eCflNlhO https://t.co/wivvWqyWuf

    • Mashup Score: 3
      Up and down the ladder: The latest comings and goings - 3 day(s) ago

      From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

      Source: www.statnews.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	pharmalot
        pharmalot

        Up and Down the Ladder: Job Changes.. the latest comings & goings.. recognize anyone? https://t.co/GnuAHElRgE #pharma #biotech #jobs $BMY $SNY $AZN $PFE

    • Mashup Score: 9
      Combining Alpha and Beta Emitters in PSMA-Targeted Prostate Cancer Therapy - Scott Tagawa - 3 day(s) ago

      Pedro Barata interviews Scott Tagawa about radioligand therapy research, focusing on actinium-225 PSMA antibody constructs. Dr. Tagawa explains that antibodies like rosopatamab offer advantages over small molecules by circulating longer in the bloodstream, providing multiple targeting opportunities over days rather than hours, particularly beneficial for lower PSMA-expressing tumors. His…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        Combining alpha and beta emitters in PSMA-targeted #ProstateCancer therapy. @DrScottTagawa @WeillCornell joins @PBarataMD @caseccc to discuss radioligand therapy research, focusing on actinium-225 PSMA antibody constructs. #WatchNow > https://t.co/ejgbnjmZPP https://t.co/pK2mXKwuOx

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings